IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers
IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers
Active, not recruiting · NCT06790706 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers | Female Urogenital Diseases and Pregnancy Complications, Gestational Trophoblastic Disease, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pregnancy Complications, Neoplastic, Thoracic Neoplasms, Thymus Neoplasms, Urogenital Diseases, adenocarcinoma, carcinoid tumor, carcinoma, digestive system neuroendocrine neoplasm, epithelial neoplasm, gestational trophoblastic neoplasm, lymphatic system disorder, mixed neoplasm, neoplasm, neuroendocrine neoplasm, peritoneal mesothelioma, pregnancy disorder, primitive neuroectodermal tumor, thymoma, thyroid gland undifferentiated (anaplastic) carcinoma, trophoblastic neoplasm | Active, not recruiting | Phase 2 | 2026-06-25 | NCT06790706 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospices Civils de Lyon | 429 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.